These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacological treatment of erectile dysfunction after radical prostatectomy. Dennis RL; McDougal WS J Urol; 1988 Apr; 139(4):775-6. PubMed ID: 3352040 [TBL] [Abstract][Full Text] [Related]
4. [Penile self-injection of a papaverine-phentolamine combination, as treatment of impotence, in patients treated with radical cystoprostatectomy]. Calahorra Fernández FJ; RodrÃguez A; Castro M; Tamayo JC; Alvarez E; Leiva O Actas Urol Esp; 1991; 15(1):43-5. PubMed ID: 2058441 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological erection: diagnosis and treatment applications in 69 patients. Nellans RE; Ellis LR; Kramer-Levien D J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712 [TBL] [Abstract][Full Text] [Related]
6. The management of impotence following pelvic surgery. Brosman S Prog Clin Biol Res; 1988; 260():419-28. PubMed ID: 3362901 [No Abstract] [Full Text] [Related]
7. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients. Sidi AA; Cameron JS; Duffy LM; Lange PH J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014 [TBL] [Abstract][Full Text] [Related]
8. Impotence: treatment by autoinjection of vasoactive drugs. Williams G; Mulcahy MJ; Kiely EA Br Med J (Clin Res Ed); 1987 Sep; 295(6598):595-6. PubMed ID: 3117249 [TBL] [Abstract][Full Text] [Related]
9. [Action of vasoactive drugs in male sexual impotence]. Morales JC; Elizondo B Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491 [TBL] [Abstract][Full Text] [Related]
11. Intracavernous self-injection of papaverine in the treatment of erectile impotence after major pelvic surgery. van Driel MF; de Vries AI; Mensink HJ J Enterostomal Ther; 1987; 14(3):101-4. PubMed ID: 3647048 [No Abstract] [Full Text] [Related]
12. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. Lee LM; Stevenson RW; Szasz G J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589 [TBL] [Abstract][Full Text] [Related]
13. Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation. Hadzija BW; Mattocks AM; Stahl GM J Urol; 1988 Jul; 140(1):64-5. PubMed ID: 2454330 [TBL] [Abstract][Full Text] [Related]
14. Physiology of erection and pharmacological management of impotence. Lue TF; Tanagho EA J Urol; 1987 May; 137(5):829-36. PubMed ID: 3553617 [No Abstract] [Full Text] [Related]
15. Intracavernous injection of vasoactive drugs after radical prostatectomy. Goldstein M J Urol; 1988 Apr; 139(4):800. PubMed ID: 3352048 [No Abstract] [Full Text] [Related]
17. [Intracavernous injection of vasoactive drugs for treating erectile impotence]. Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019 [TBL] [Abstract][Full Text] [Related]
18. Intracavernous injections for impotence. Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212 [No Abstract] [Full Text] [Related]
19. How safe is the treatment of impotence with intracavernous autoinjection? Zentgraf M; Ludwig G; Ziegler M Eur Urol; 1989; 16(3):165-71. PubMed ID: 2663519 [TBL] [Abstract][Full Text] [Related]